Takeshi Yasumoto Selected Research

polycavernoside A

1/2007	Effects of a synthetic analog of polycavernoside A on human neuroblastoma cells.
9/2004	Identification of polycavernoside A as the causative agent of the fatal food poisoning resulting from ingestion of the red Alga Gracilaria edulis in the Philippines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Yasumoto Research Topics

Disease

10	Poisoning 01/2021 - 01/2002
7	Neuroblastoma 02/2009 - 06/2002
6	Ciguatera Poisoning (Ciguatera) 01/2021 - 05/2005
3	Shellfish Poisoning 02/2018 - 01/2010
3	Foodborne Diseases 01/2017 - 09/2004
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2013 - 12/2008
2	Neoplasms (Cancer) 10/2012 - 12/2008
1	Smallpox (Variola) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2015
1	Osteosarcoma (Osteogenic Sarcoma) 10/2013
1	T-Cell Leukemia (Leukemia, T Cell) 10/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2012
1	Hodgkin Disease (Hodgkin's Disease) 10/2012
1	Inflammation (Inflammations) 04/2012
1	Leukemia 04/2012
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2011
1	Primary Effusion Lymphoma 01/2011
1	Wounds and Injuries (Trauma) 09/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2008
1	Edema (Dropsy) 03/2008
1	Diarrhea 03/2008
1	Neoplasm Metastasis (Metastasis) 10/2006
1	Breast Neoplasms (Breast Cancer) 09/2004

Drug/Important Bio-Agent (IBA)

7	CiguatoxinsIBA 01/2021 - 05/2005
4	fucoxanthinolIBA 10/2013 - 12/2008
4	fucoxanthinIBA 10/2013 - 12/2008
4	palytoxinIBA 01/2013 - 04/2007
3	Actins (F Actin)IBA 03/2008 - 06/2002
3	gambierolIBA 09/2006 - 05/2005
3	azaspiracidIBA 02/2003 - 01/2002
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2013 - 01/2010
2	polycavernoside AIBA 01/2007 - 09/2004
2	Fura-2 (Fura 2)IBA 01/2007 - 01/2006
2	bis(1,3- diethylthiobarbiturate)trimethineoxonolIBA 01/2007 - 01/2006
2	CalciumIBA 01/2007 - 01/2006
2	Cadherins (E-Cadherin)IBA 10/2006 - 09/2004
1	SolventsIBA 03/2020
1	MacrolidesIBA 02/2018
1	cyanoginosin LR (microcystin LR)IBA 10/2015
1	dinophysistoxin 1IBA 11/2013
1	Serine (L-Serine)FDA Link 10/2013
1	Threonine (L-Threonine)FDA Link 10/2013
1	Carotenoids (Carotene)IBA 10/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Marine ToxinsIBA 01/2013
1	GlucosidesIBA 04/2012
1	okicamelliasideIBA 04/2012
1	InterleukinsIBA 04/2012
1	Ellagic AcidIBA 04/2012
1	Ketotifen (Ketotifene)FDA Link 04/2012
1	CytokinesIBA 04/2012
1	Anti-Allergic Agents (Antiallergic Agents)IBA 04/2012
1	Complex MixturesIBA 04/2012
1	tranilastIBA 04/2012
1	AntigensIBA 04/2012
1	ProstaglandinsIBA 04/2012
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	Interleukin-13IBA 04/2012
1	Okadaic AcidIBA 01/2010
1	EnzymesIBA 01/2010
1	ostreocin DIBA 02/2009
1	Adenosine Triphosphatases (ATPase)IBA 02/2009
1	Ouabain (G Strophanthin)IBA 02/2009
1	pectenotoxin 6IBA 03/2008
1	oregon green 514IBA 03/2008
1	PhalloidineIBA 03/2008
1	Coloring Agents (Dyes)IBA 03/2008
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2007
1	CateninsIBA 10/2006
1	Ion Channels (Ion Channel)IBA 09/2006
1	Ether (Diethyl Ether)IBA 09/2006
1	VeratridineIBA 01/2006
1	scorpion toxin I''IBA 01/2006
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2005
1	Voltage-Gated Sodium ChannelsIBA 05/2005
1	aplysiatoxinIBA 05/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2011
1	Intravenous Administration 09/2009
1	Sublingual Administration 09/2009